BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22569581)

  • 1. Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients.
    Cassandrini D; Cilio MR; Bianchi M; Doimo M; Balestri M; Tessa A; Rizza T; Sartori G; Meschini MC; Nesti C; Tozzi G; Petruzzella V; Piemonte F; Bisceglia L; Bruno C; Dionisi-Vici C; D'Amico A; Fattori F; Carrozzo R; Salviati L; Santorelli FM; Bertini E
    J Inherit Metab Dis; 2013 Jan; 36(1):43-53. PubMed ID: 22569581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient with pontocerebellar hypoplasia type 6: Novel RARS2 mutations, comparison to previously published patients and clinical distinction from PEHO syndrome.
    Nevanlinna V; Konovalova S; Ceulemans B; Muona M; Laari A; Hilander T; Gorski K; Valanne L; Anttonen AK; Tyynismaa H; Courage C; Lehesjoki AE
    Eur J Med Genet; 2020 Mar; 63(3):103766. PubMed ID: 31536827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel homozygous RARS2 mutation in two siblings without pontocerebellar hypoplasia - further expansion of the phenotypic spectrum.
    Lühl S; Bode H; Schlötzer W; Bartsakoulia M; Horvath R; Abicht A; Stenzel M; Kirschner J; Grünert SC
    Orphanet J Rare Dis; 2016 Oct; 11(1):140. PubMed ID: 27769281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subdural effusions and lack of early pontocerebellar hypoplasia in siblings with RARS2 mutations.
    Kastrissianakis K; Anand G; Quaghebeur G; Price S; Prabhakar P; Marinova J; Brown G; McShane T
    Arch Dis Child; 2013 Dec; 98(12):1004-7. PubMed ID: 24047924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic analysis of infants with pontocerebellar hypoplasia type 6 caused by RARS2 variations.
    Zhao S; Lian R; Jin L; Li M; Jia T; Xu F; Du K; Wang L; Guo Q; Dong Y
    Epilepsia Open; 2024 Feb; 9(1):250-257. PubMed ID: 38009286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early onset epileptic encephalopathy caused by mitochondrial arginyl-tRNA synthetase gene deficiency: report of two cases and literature review].
    Jiang HF; Deng J; Fang F; Li H; Wang XH; Dai LF
    Zhonghua Er Ke Za Zhi; 2020 Nov; 58(11):893-899. PubMed ID: 33120460
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia.
    Namavar Y; Barth PG; Kasher PR; van Ruissen F; Brockmann K; Bernert G; Writzl K; Ventura K; Cheng EY; Ferriero DM; Basel-Vanagaite L; Eggens VR; Krägeloh-Mann I; De Meirleir L; King M; Graham JM; von Moers A; Knoers N; Sztriha L; Korinthenberg R; ; Dobyns WB; Baas F; Poll-The BT
    Brain; 2011 Jan; 134(Pt 1):143-56. PubMed ID: 20952379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RARS2 mutations in a sibship with infantile spasms.
    Ngoh A; Bras J; Guerreiro R; Meyer E; McTague A; Dawson E; Mankad K; Gunny R; Clayton P; Mills PB; Thornton R; Lai M; Forsyth R; Kurian MA
    Epilepsia; 2016 May; 57(5):e97-e102. PubMed ID: 27061686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded clinical phenotype and untargeted metabolomics analysis in RARS2-related mitochondrial disorder: a case report.
    Walimbe AS; Machol K; Kralik SF; Mizerik EA; Gofin Y; Bekheirnia MR; Gijavanekar C; Elsea SH; Emrick LT; Scaglia F
    BMC Neurol; 2024 Mar; 24(1):87. PubMed ID: 38438854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase, RARS2.
    Glamuzina E; Brown R; Hogarth K; Saunders D; Russell-Eggitt I; Pitt M; de Sousa C; Rahman S; Brown G; Grunewald S
    J Inherit Metab Dis; 2012 May; 35(3):459-67. PubMed ID: 22086604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the promoter of RARS2 causes pontocerebellar hypoplasia in two siblings.
    Li Z; Schonberg R; Guidugli L; Johnson AK; Arnovitz S; Yang S; Scafidi J; Summar ML; Vezina G; Das S; Chapman K; del Gaudio D
    J Hum Genet; 2015 Jul; 60(7):363-9. PubMed ID: 25809939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel RARS2 Variants: Updating the Diagnosis and Pathogenesis of Pontocerebellar Hypoplasia Type 6.
    Zhang Y; Yu Y; Zhao X; Xu Y; Chen L; Li N; Yao R; Wang J; Yu T
    Pediatr Neurol; 2022 Jun; 131():30-41. PubMed ID: 35468344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathologic Characterization of Pontocerebellar Hypoplasia Type 6 Associated With Cardiomyopathy and Hydrops Fetalis and Severe Multisystem Respiratory Chain Deficiency due to Novel RARS2 Mutations.
    Lax NZ; Alston CL; Schon K; Park SM; Krishnakumar D; He L; Falkous G; Ogilvy-Stuart A; Lees C; King RH; Hargreaves IP; Brown GK; McFarland R; Dean AF; Taylor RW
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):688-703. PubMed ID: 26083569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia.
    Edvardson S; Shaag A; Kolesnikova O; Gomori JM; Tarassov I; Einbinder T; Saada A; Elpeleg O
    Am J Hum Genet; 2007 Oct; 81(4):857-62. PubMed ID: 17847012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RARS2 mutations cause early onset epileptic encephalopathy without ponto-cerebellar hypoplasia.
    Nishri D; Goldberg-Stern H; Noyman I; Blumkin L; Kivity S; Saitsu H; Nakashima M; Matsumoto N; Leshinsky-Silver E; Lerman-Sagie T; Lev D
    Eur J Paediatr Neurol; 2016 May; 20(3):412-7. PubMed ID: 26970947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct magnetic resonance imaging features in a patient with novel
    Zhang J; Zhang Z; Zhang Y; Wu Y
    Exp Ther Med; 2018 Jan; 15(1):1099-1104. PubMed ID: 29434700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-coding variant in the Kozak sequence of RARS2 strongly decreases protein levels and causes pontocerebellar hypoplasia.
    Nicolle R; Altin N; Siquier-Pernet K; Salignac S; Blanc P; Munnich A; Bole-Feysot C; Malan V; Caron B; Nitschké P; Desguerre I; Boddaert N; Rio M; Rausell A; Cantagrel V
    BMC Med Genomics; 2023 Jun; 16(1):143. PubMed ID: 37344844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia.
    Namavar Y; Barth PG; Poll-The BT; Baas F
    Orphanet J Rare Dis; 2011 Jul; 6():50. PubMed ID: 21749694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pontocerebellar hypoplasia type 2 and TSEN2: review of the literature and two novel mutations.
    Bierhals T; Korenke GC; Uyanik G; Kutsche K
    Eur J Med Genet; 2013 Jun; 56(6):325-30. PubMed ID: 23562994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pontocerebellar hypoplasia type 6: A British case with PEHO-like features.
    Rankin J; Brown R; Dobyns WB; Harington J; Patel J; Quinn M; Brown G
    Am J Med Genet A; 2010 Aug; 152A(8):2079-84. PubMed ID: 20635367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.